Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF‐κB Signaling Pathway

Objective To investigate the changes in proinflammatory cytokines and chemokines, namely, C‐C motif ligand (CCL) 2 and CCL7, in postmenopausal osteoporosis (PMOP) and to develop a new drug, bindarit (Bnd), for PMOP in an ovariectomized (OVX) mouse model. Methods Bone marrow macrophages (BMMs) from t...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Shi‐guo Yuan, Hong‐ling Hu, Xin‐jia Wang, Jin‐cheng Yang, Rong‐ping Zhou, Xiao‐chun Bai, Ping‐lin Lai
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2022-06-01
Saila:	Orthopaedic Surgery
Gaiak:	Bindarit MCP‐1 MCP‐3 Osteoclastogenesis Osteoporosis
Sarrera elektronikoa:	https://doi.org/10.1111/os.13252
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!